You are on page 1of 40

Illinois Council of Health-System Pharmacists 2016 Annual Meeting

LEADERSHIP: IT’S NOT JUST FOR LEADERS


September 15 - 17, 2016 | Oakbrook Terrace, Illinois

SYLLABUS
WIFI
ICHP MEETING Netwo
rk: ichp
2016
2016

MOBILE APP a s s w o rd: ichp


P

Get the most out of ICHP’s Annual Meeting with your


smartphone. Users can create their own custom schedule,
view handouts, browse exhibits, receive timely announce-
ments, share photos, connect with speakers, exhibitors and
other attendees, and much more.

Available NOW in app stores


for Android™ and iPhone®.

A D N O W nt!
OW N LO al Meeting conte
D u
to-date Ann
For the most up-

Introducing ICHPchat
ICHP staff is pleased to announce the launch of
our all new online community, ICHPchat! This
online community is exclusive to ICHP members
and allows members to connect with each other
in social forums by asking questions, sharing best
practices, attaching files, and more.

To get started, visit ICHPchat.org to create your


account and check out our Getting Started Guide.
2016 ANNUAL MEETING PLANNING COMMITTEE

CONTENTS
Maggie DiMarco Allen Charlene Hope Marco Martino
Jill Borchert Travis Hunerdosse, Scott Meyers
Whitnee Caldwell Co-Chair Kushal Shah
Larry Danziger Ayesha Khan David Tjhio
Lara Ellinger, Co-Chair Oksana Kucher Trish Wegner
Acknowledgements 3 Clara Gary David Martin Susan Winkler

Meeting-At-A-Glance 4 2016 ANNUAL MEETING VOLUNTEERS


Carol Heunisch Jessica Peng Kathryn Schultz
Conference Center Map 5 Brittany Huff Jennifer Phillips Katherine Sencion

Meeting Sponsors 5 ICHP OFFICERS AND BOARD OF DIRECTORS


Jennifer Phillips, President ICHP AFFILIATE PRESIDENTS
General Meeting Mike Fotis, Immediate Past Kathryn Schultz, Northern
President Illinois Society
Information 6 Charlene Hope, President-Elect Jared Sheley,
Mike Weaver, Treasurer Metro East Society
Accreditation Information 7 Kathy Komperda, Secretary Amy Boblitt, Sangamiss Society
Travis Hunerdosse, Director, Ed Rainville, West Central
Educational Affairs Society
Audience Response Carrie Vogler, Director, Marketing Vacant - President, Rock Valley
Affairs Society; Southern IL Society, Sugar
Device Instructions 7 Kristi Stice, Director, Professional Creek Society
Affairs
Carol Heunisch, Director, ICHP STUDENT CHAPTER
Thursday 9 Organizational Affairs PRESIDENTS
Kathryn Schultz, Director, Florence Patino, Chicago State
Friday 16 Government Affairs University College of Pharmacy
Ann Jankiewicz, Chairman, Shaziya Barkat, Midwestern
House of Delegates University Chicago College of
Keynote 17 David Tjhio, Chairman, Pharmacy
Committee on Technology Katarzyna Plis, Roosevelt
Rebecca Castner, Chairman, New University College of Pharmacy
Saturday 23 Practitioners Network Jorie Kreitman, Rosalind
Bryan McCarthy, Co-Chair, Franklin University College of
Ambulatory Care Network Pharmacy
CPE Credit Instructions 28 Virginia Nash, Co-Chair, Mallory Belcher, Southern
Ambulatory Care Network Illinois University Edwardsville
Jacob Gettig, Editor & School of Pharmacy
Faculty and Chairman, KeePosted Committee Levi Pilones, University of
Disclosures Listing 30 Jennifer Phillips, Illinois College of Pharmacy -
Assistant Editor, KeePosted Chicago
Scott Meyers, Executive Vice Trevor Luman, University of
Residency Showcase 33 President Illinois College of Pharmacy -
Vacant - Technician Representative Rockford

Exhibitor Listing 34 ICHP REGIONAL DIRECTORS


Noelle Chapman, North
Ed Rainville, Central
Pages for Notes 35 Lynn Fromm, Co-Director South
Tara Vickery Gorden, Co-Director
South
Upcoming Events 39

ICHP OFFICE STAFF


Scott Meyers, Heidi Sunday, Jo Haley,
Executive Vice Information Systems Customer Service
President Manager Representative and
Trish Wegner, Vice Amanda Wolff, Pharmacy Tech
President of Communications Topics™ Specialist
Professional Services Manager Jim Owen, Legislative
Maggie DiMarco Allen, Jan Mark, Consultant
Director of Accountant
Operations and Trisha Blassage,
Continuing Education Accountant
Administrator

LEADERSHIP: IT’S NOT JUST FOR LEADERS! 3


ICHP 2016 ANNUAL MEETING

MEETING-AT-A-GLANCE
LEADERSHIP: IT’S NOT JUST FOR LEADERS
September 15 - 17, 2016 | Oakbrook Terrace, Illinois

2016 ANNUAL MEETING GENERAL LEARNING OBJECTIVES


1. Recognize the importance of leadership in any professional career or situation.
2. Describe medication safety issues and processes.
3. Address current issues in clinical practice.
4. State the relationship between pharmacy and the pharmaceutical industry.
5. Outline various technologies to assist in improving patient outcomes.
6. Define areas impacting the practice for pharmacy technicians.
7. Identify new services for pharmacists and pharmacy technicians.

THURSDAY, SEPTEMBER 15, 2016 – Presented in partnership with the Pharmacy Learning Network.
Time Session/Event Room
7:00am - 6:15pm ICHP Registration Desk Hours Foyer
7:00am - 8:00am Innovation Theater Breakfast Venetian Room
8:00am - 11:45am General Sessions Terrace Room
11:45am - 12:45pm Innovation Theater Lunches I & II Venetian Room & Crystal
Rooms I & II
11:45am - 12:45pm Past Presidents’ Lunch (invitation only) English Room
12:45pm - 2:00pm General Sessions Terrace Room
2:00pm - 3:00pm Afternoon Break & Innovation Theater Venetian Room
3:00pm - 4:25pm Exhibit Program Oak & Brook Rooms
4:25pm - 6:10pm General Sessions Terrace Room
6:15pm - 8:00pm House of Delegates Crystal Rooms I & II
FRIDAY, SEPTEMBER 16, 2016
Time Session/Event Room
7:00am - 5:45pm ICHP Registration Desk Hours Foyer
7:00am - 8:00am Continental Breakfast Foyer
8:00am - 10:00am General Session Terrace & Venetian Rooms
8:00am - 10:00am Reverse Exhibit (invitation only) Crystal Room
10:00am - 12:00pm Exhibit Program and Reception Oak & Brook Rooms
12:00pm - 1:00pm Lunch & Town Hall Meeting Terrace & Venetian Rooms
1:15pm - 2:40pm Keynote Session Terrace & Venetian Rooms
2:45pm - 5:45pm Track 1 - Pharmacy Technology Session Crystal Room
2:45pm - 5:45pm Track 2 - Clinical Session Terrace & Venetian Rooms
5:45pm - 7:00pm NPN Mixer Foyer
7:00pm - 9:30pm President’s Dinner (invitation only) Reel Club
SATURDAY, SEPTEMBER 17, 2016
Time Session/Event Room
7:30am - 3:15pm ICHP Registration Desk Hours Foyer
7:30am - 8:00am Continental Breakfast Foyer
8:00am - 11:30am Track 1 - Technician Session English Room
8:00am - 11:30am Track 2 - Pharmacy Practice Session Crystal Room
8:00am - 11:30am Track 3 - Student Session Venetian Room
11:30am - 1:00pm Lunch & Awards Program Terrace Room
1:00pm - 3:00pm Closing General Session Crystal Room
1:00pm - 3:00pm Residency Showcase Oak & Brook Rooms
DRURY LANE CONFERENCE CENTER MAP
Main Entrance ICHP Registration Desk Meeting Rooms
MAIN ENTRANCE
 



 
 











 


  
 

 




  



registration

PAC AUCTION
 
 

FOYER 




    


CRYSTAL VENETIAN TERRACE BROOK OAK ENGLISH



   

   

   

   

 


   

  Exhibit Hall and 


 Residency Showcase 
 

 






THANK YOU MEETING SPONSORSHIPS


ICHP would like to thank these companies for providing sponsorships for the 2016 Annual Meeting.

PLATINUM SPONSOR GOLD SPONSOR

SILVER SPONSORS

LEADERSHIP: IT’S NOT JUST FOR LEADERS! 5


GENERAL MEETING INFO
REGISTRATION WIFI PROGRAM EVALUATIONS
Meeting materials are available for Complimentary meeting WiFi AND CREDIT
pick-up during designated hours at provided by Drury Lane and ICHP ACCREDITED PROGRAMMING
the meeting. CPE handouts will be ICHP. In order to receive continuing
available online prior to the meet- Network: ichp2016 pharmacy education (CPE) credit,
ing. The ICHP registration desk will Password: ichp2016 all meeting attendees will need to
be located in the conference center access CESally.com to complete
foyer. Registration desk hours are: evaluations. Credit will be re-
THURSDAY, SEPTEMBER 15 TARGET AUDIENCE ported to CPE Monitor.
7:00 AM - 6:15 PM Health-system pharmacists and
FRIDAY, SEPTEMBER 16 pharmacy technicians; pharmacy You will have until Monday, Oc-
7:00 AM - 5:45 PM students. tober 31, 2016 to complete your
online evaluations and submit
SATURDAY, SEPTEMBER 17
your request for CPE credit. Do
7:30 AM - 3:15 PM
CONTINUING PHARMACY not delay in completing your
EDUCATION CREDIT ICHP evaluations. Instructions
Education sessions will be offered for completing ICHP live program
MEETING DRESS CODE
for CPE credit and registrants evaluations online are included in
The meeting dress code is busi- the syllabus on page 28-29. When
may earn up to 18 contact hours
ness casual. The meeting room completing your program evalu-
(1.8 CEUs) at this meeting (ICHP
temperatures may vary – please ation for credit, if a CPE program
determines the number of contact
remember to bring a sweater or number ends in both ‘P’ and ‘T’,
hours for each ICHP session).
jacket. pharmacists must choose the ‘P’
Please note: PTCB requires CPhTs program and technicians must
to earn only pharmacy technician- choose the ‘T’ program.
NAME BADGES specific (‘T-specific’) credit to qualify
Badges should be worn at all times for recertification. As of January 1, CIHE ACCREDITED PROGRAMMING
as a courtesy to other meeting 2015, ALL CPE credit earned must be To receive credit, participants must
participants. Your badge is your T-specific. In addition, PTCB reduced complete and return the Activity
admission pass for all meeting ses- the number of allowable CPE hours Evaluation Form. The informa-
sions and exhibits, and indicates earned through in-service training tion that you participated will be
any dietary restrictions. from 10 to 5. uploaded to CPE Monitor within 4
weeks, and you will be able to access
your credits from your NABP profile.
ARRANGEMENTS FOR CPE MONITOR
SPECIAL ASSISTANCE Your NABP e-Profile ID is re- NACCME ACCREDITED
If you have any disability for quired to receive CPE credit. PROGRAMMING
which you may require an auxil- Visit www.mycpemonitor.net Instructions for North American
iary aid or special service while for more information. Center for Continuing Medical
attending the meeting, please talk Education, LLC (NACCME) will be
to the ICHP staff at the registra- provided on site.
tion desk. PROGRAMMING
Program variations may occur. PLEASE REFER TO THE DETAILED
Syllabus includes all available SCHEDULE FOR COMPLETE
information at time of print on ACCREDITATION INFORMATION ON
September 1, 2016. EACH PROGRAM.

6 2016 ICHP ANNUAL MEETING


ACCREDITATION ACPE UNIVERSAL MEETING
The Illinois Council ACTIVITY NUMBERS PARTNERSHIP
of Health-System ICHP Thursday’s programming
Pharmacists (ICHP) 0121-0000-16-064-L03-P presented in partnership with the Phar-
and The Center 0121-0000-16-064-L03-T macy Learning Network (PLN).
for Independent 0121-0000-16-065-L04-P North American Center for Con-
Healthcare Education (CIHE) are 0121-0000-16-065-L04-T tinuing Medical Education, LLC
accredited by the Accreditation 0121-0000-16-066-L04-P (NACCME) is accredited by the Ac-
Council for Pharmacy Education 0121-0000-16-066-L04-T creditation Council for Continuing
(ACPE) as providers of continuing 0121-0000-16-067-L04-P Medical Education (ACCME), the
pharmacy education. Registrants 0121-0000-16-067-L04-T Accreditation Council for Pharmacy
at the 2016 ICHP Annual Meeting 0121-0000-16-068-L04-P Education (ACPE), and the American
may earn a maximum of 18 con- 0121-0000-16-068-L04-T Nurses Credentialing Center (ANCC)
tact hours of continuing pharmacy 0121-0000-16-069-L04-P to provide continuing education for
education in states that recognize 0121-0000-16-069-L04-T the health care team.
ACPE providers (11.5 contact hours 0121-0000-16-070-L01-P
from ICHP; 6.5 contact hours from 0121-0000-16-071-L01-T CPE
NACCME – see below; 1 contact 0121-0000-16-072-L01-P Each of these activities is approved
hour from CIHE). Please refer to the 0121-0000-16-072-L01-T for .75 contact hour (0.075 CEU) of
full meeting syllabus for complete 0121-0000-16-073-L04-P continuing pharmacy education
accreditation information. 0121-0000-16-073-L04-T (UANs 0276-0000-16-128-L01-P,
0121-0000-16-074-L05-P 0276-0000-16-026-L01-P, 0276-0000-
0121-0000-16-074-L05-T 16-027-L01-P, 0276-0000-16-142-L01-
AUDIENCE RESPONSE DEVICE 0121-0000-16-075-L04-P P, 0276-0000-16-142-L01-T).
INSTRUCTIONS 0121-0000-16-075-L04-T
0121-0000-16-076-L04-P Each of these activities is approved
For Friday and Saturday programming only.
0121-0000-16-076-L04-T for .5 contact hour (0.05 CEU) of
To program your device, please continuing pharmacy education
0121-0000-16-077-L04-P
follow these steps: (UANs 0276-0000-16-028-L05-P,
0121-0000-16-078-L04-P
1. Press and release the “Ch” 0276-0000-16-029-L01-P, 0276-
0121-0000-16-079-L04-P
(channel) button 0000-16-031-L01-P, 0276-0000-16-
0121-0000-16-079-L04-T
2. While the light is flashing red 131-L05-P, 0276-0000-16-032-L01-P,
0121-0000-16-080-L01-P
and green, enter the number 0276-0000-16-033-L01-P, 0276-0000-
0121-0000-16-080-L01-T
provided by the moderator 16-034-L01-P).
(different rooms will have CIHE
Each of these activities is approved
different numbers) 0473-9999-16-004-L01-P
for .5 contact hour (0.05 CEU) of
3. Now press and release the “Ch”
continuing pharmacy technician
(channel) button again
education (UANs 0276-0000-16-
4. The light should be solid green
029-L01-T, 0276-0000-16-131-L05-T,
to confirm communication with
0276-0000-16-028-L05-T, 0276-
the receiver
0000-16-032-L01–T).
Please turn in your Audience Response
Device at the ICHP Registration Desk on These educational activities
the last day you attend the meeting. are knowledge-based activities.
Instructions for NACCME will be
provided on site.
For questions regarding PLN
activities, please call 609-371-1137.

LEADERSHIP: IT’S NOT JUST FOR LEADERS! 7


REV RUN JUSTINE SIMMONS
Hip-hop Legend Wife and Mother
Novo Nordisk Ambassador Novo Nordisk Ambassador

Follow Rev Run @RevRunWisdom

More than 1 in 3 American adults are at risk of type 2 diabetes1 and African
Americans are nearly twice as likely to develop diabetes as Caucasian
Americans.2 Knowing if you are at risk of type 2 diabetes doesn’t just
affect you—it affects your family, too.

Find out your diabetes risk factors today at AskScreenKnow.com,


and encourage others to do the same.

References:
1 Tarasova VD, Caballero JA, Turner P, Inzucchi SE. Speaking to patients about diabetes risk: is terminology important? Clinical Diabetes. 2014;32(2):90-95.
2 Treatment and Care for African Americans. American Diabetes Association website. http://www.diabetes.org/living-with-diabetes/treatment-and-care/
high-risk-populations/treatment-african-americans.html. Published November 12, 2013. Updated October 1, 2014. Accessed March 30, 2016.

Novo Nordisk and Ask.Screen.Know.® are registered trademarks of Novo Nordisk A/S.
© 2016 Novo Nordisk Printed in the U.S.A. USA16PCT01316 April 2016
THURSDAY, SEPTEMBER 15

7:00AM - 8:00AM 8:45AM - 9:30AM


THURSDAY Venetian Room Terrace Room
AT-A-GLANCE INNOVATION THEATER ENSURING SAFE AND
Presented in partnership with the Pharmacy BREAKFAST EFFECTIVE TREATMENT OF
Learning Network.
Sponsored by Merck & Co., Inc. INVASIVE FUNGAL INFECTIONS
7:00AM - 6:15PM At the end of this presentation,
ICHP REGISTRATION DESK HOURS pharmacist participants should be
Foyer GENERAL SESSION able to:
8:00AM - 8:15AM 1. Outline guideline recommen-
7:00AM - 8:00AM Terrace Room dations and best practices for
INNOVATION THEATER BREAKFAST individualized management of
INTRODUCTION
Venetian Room patients with IFIs.
Randolph V. Fugit, PharmD, BCPS
2. Describe the mechanisms-of-
8:00AM - 11:45AM action, efficacy/safety, and tol-
GENERAL SESSIONS erability of newer and emerging
Terrace Room 8:15AM - 8:45AM antifungal therapies for IFIs.
Terrace Room 3. Provide clinicians with expert
11:45AM - 12:45PM A CHANGING PARADIGM IN therapeutic advice on preven-
INNOVATION THEATER tative, empiric, and targeted
LUNCHES I & II
CANCER CARE: THE MIGRATION antifungal treatment selection.
Venetian Room & Crystal Rooms I & II TO ORAL ONCOLYTIC AGENTS 4. Vigilantly monitor IFI patients
At the end of this presentation, to ensure appropriate medica-
11:45AM - 12:45PM pharmacist participants should be tion modifications, reconcilia-
PAST PRESIDENTS’ LUNCH able to: tion, and prevention of toxici-
(invitation only) 1. Describe the pharmacologic ties and drug interactions.
English Room mechanisms and indications of Type of Activity: Knowledge-based
newly available oral agents to 0.75 contact hour (0.075 CEU)
12:45PM - 2:00PM treat various cancers. UAN: 0276-0000-16-026-L01-P
GENERAL SESSIONS 2. Evaluate the reported toxicities James S. Lewis II, PharmD, FIDSA
Terrace Room for newer oral oncolytic drugs
and discuss the therapeutic im-
2:00PM - 3:00PM plications of these toxicities.
AFTERNOON BREAK & 3. Review the factors that impact
INNOVATION THEATER the potential success of treat-
Venetian Room ment with oral oncolytic drugs
such as compliance and drug
3:00PM - 4:25PM procurement.
EXHIBIT PROGRAM At the end of this presentation,
Oak & Brook Rooms technician participants should be
able to:
4:25PM - 6:10PM 1. Describe the indications for
GENERAL SESSIONS newly available oral agents to
Terrace Room treat various cancers.
2. List the side effects for newer
6:15PM - 8:00PM oral oncolytic drugs.
HOUSE OF DELEGATES 3. Review the potential success
Crystal Rooms I & II of treatment with oral on-
colytic drugs related to drug
procurement.
Type of Activity: Knowledge-based
0.5 contact hour (0.05 CEU)
UANs: 0276-0000-16-029-L01-P
0276-0000-16-029-L01-T
Christopher A. Fausel, PharmD,
BCPS, BCOP
LEADERSHIP: IT’S NOT JUST FOR LEADERS! 9
THURSDAY, SEPTEMBER 15

9:30AM - 10:00AM 10:00AM - 10:30AM 10:30AM - 11:00AM


Terrace Room Terrace Room Terrace Room
A MULTIDISCIPLINARY IMPROVING LONG TERM PREVENTING ERRORS:
APPROACH TO PREVENTING OUTCOMES IN HEART FAILURE: LOOK- AND SOUND-ALIKE
MEDICATION ERRORS PRACTICAL IMPLICATIONS FOR MEDICATIONS
ASSOCIATED WITH INSULIN PHARMACISTS At the end of this presentation,
THERAPY At the end of this presentation, pharmacist participants should be
pharmacist participants should be able to:
At the end of this presentation,
able to: 1. Identify the types of medica-
pharmacist participants should be
1. Recognize and classify Heart tion errors that are the result
able to:
Failure patients according to of look-alike and sound-alike
1. Describe common preventable
disease stage and class. names.
adverse events with insulin
2. Review current guidelines for 2. Describe strategies for health-
therapy and their causes.
the pharmacologic treatment system pharmacists for reduc-
2. Illustrate the importance of
and management of patients ing errors due to similarity in
preventing errors through im-
with chronic heart failure. drug names.
proved order communication,
3. Assess clinical evidence on exist- At the end of this presentation,
administration, monitoring,
ing and emerging treatments in technician participants should be
and patient education.
chronic heart failure to provide able to:
3. Develop a standardized ap-
personalized therapy toward 1. Identify the types of medica-
proach to the use of insulin
decreasing hospitalizations and tion errors that are the result
throughout the medication use
mortality. of look-alike and soundalike
process.
4. Develop strategies to maximize names.
4. Describe strategies healthcare
cost-effectiveness of new FDA- 2. Describe strategies for health-
practitioners can use to prevent
approved heart failure drugs. system pharmacy technicians
medication errors and improve
Type of Activity: Knowledge-based for reducing errors due to simi-
insulin therapy for the effective
0.5 contact hour (0.05 CEU) larity in drug names.
management of diabetes.
UAN: 0276-0000-16-033-L01-P Type of Activity: Knowledge-based
At the end of this presentation,
Mark A. Munger, PharmD, FCCP, 0.5 contact hour (0.05 CEU)
technician participants should be
FACC UANs: 0276-0000-16-028-L05-P
able to:
0276-0000-16-028-L05-T
1. Describe common preventable
Matthew Grissinger, RPh, FISMP,
adverse events with insulin
FASCP
therapy and their causes.
2. Illustrate the importance of
preventing errors through im-
proved order communication,
administration, monitoring,
and patient education.
3. Develop a standardized ap-
proach to the use of insulin
throughout the medication use
process.
4. Describe strategies healthcare
practitioners can use to prevent
medication errors and improve
insulin therapy for the effective
management of diabetes.
Type of Activity: Knowledge-based
0.5 contact hour (0.05 CEU)
UANs: 0276-0000-16-131-L05-P
0276-0000-16-131-L05-T
Matthew Grissinger, RPh, FISMP,
FASCP

10 2016 ICHP ANNUAL MEETING


THURSDAY, SEPTEMBER 15

11:00AM - 11:45AM 11:45AM - 12:45PM 1:30PM - 2:00PM


Terrace Room Crystal Rooms I & II Terrace Room
CLINICAL DECISION-MAKING IN INNOVATION THEATER LUNCH II: 2016 IDSA/SHEA GUIDELINE
FEBRILE NEUTROPENIA: TEFLARO FOR THE TREATMENT PREVIEW AND THE IMPACT OF
THE CRITICAL ROLE OF OF ABSSSI AND CABP NEW REGULATORY
HEALTH-SYSTEM PHARMACISTS Larry Danziger, PharmD REQUIREMENTS ON THE
At the end of this presentation, Sponsored by Allergan. HOSPITAL PHARMACIST
pharmacist participants should be Food & beverage provided by the At the end of this presentation,
able to: North American Center for pharmacist participants should be
1. Quantify the burden of FN, Continuing Medical Education. able to:
including increased hospital- 1. List the key components of an
ization, severe infections, and antibiotic stewardship program.
delays in treatment. 2. Describe the key roles of the
2. Describe guidelines and evi- 11:45AM - 12:45PM
health system pharmacist in
dence for FN risk assessment English Room antibiotic stewardship.
and prevention. PAST PRESIDENTS’ LUNCH 3. Explain the highlights of recent
3. Outline the role of granulocyte- (invitation only) antibiotic stewardship literature
colony stimulating factor (G-CSF) and government requirements.
in primary FN prevention. Type of Activity: Knowledge-based
4. Proactively make informed 0.5 contact hour (0.05 CEU)
FN treatment recommenda- GENERAL SESSION
UAN: 0276-0000-16-031-L01-P
tions and serve as an educa- 12:45PM - 1:30PM James S. Lewis II, PharmD, FIDSA
tional resource for the health- Terrace Room
care team.
DOACS AND REVERSAL AGENTS:
5. Integrate appropriate FN
prevention and management CONSIDERATIONS FOR 2:00PM - 3:00PM
strategies to improve patient HEALTH-SYSTEM PHARMACISTS Venetian Room
outcomes. At the end of this presentation, AFTERNOON BREAK &
Type of Activity: Knowledge-based pharmacist participants should be INNOVATION THEATER
0.75 contact hour (0.075 CEU) able to:
UAN: 0276-0000-16-027-L01-P Sponsored by Novo Nordisk, Inc.
1. Evaluate the role of DOACs in
Val R. Adams, PharmD, BCOP the management of VTE and AF-
related stroke risk reduction and
their associated bleeding risk. 3:00PM - 4:25PM
2. Outline the pharmacologic pro- Oak & Brook Rooms
11:45AM - 12:45PM files, clinical characteristics, pa- EXHIBIT PROGRAM
Venetian Room tient-centric considerations, and
INNOVATION THEATER LUNCH I: cost-effectiveness of DOACs.
APPROACHING THE CHALLENGE 3. Describe new and emerging
DOAC reversal agents and their 3:00PM - 4:25PM
OF TREATING PATIENTS WITH clinical utility in patients who Foyer
DIABETES WHO ARE SEVERELY may require interruption of an-
VISIT THE ICHP BEST PRACTICE
INSULIN RESISTANT ticoagulant therapy.
4. Develop or augment proto- AWARD WINNER
Rajeev K. Jain, MD, FACE
cols for patients requiring the
Sponsored by Lilly. prompt reversal of DOACs
Food & beverage provided by the due to risk of bleeding, severe
North American Center for bleeding, or urgent/emergent
Continuing Medical Education. invasive procedures.
Type of Activity: Knowledge-based
0.75 contact hour (0.075 CEU)
UAN: 0276-0000-16-128-L01-P
Mark A. Munger, PharmD, FCCP,
FACC

LEADERSHIP: IT’S NOT JUST FOR LEADERS! 11


THURSDAY, SEPTEMBER 15

GENERAL SESSION 5:10PM - 5:40PM 5:40PM - 6:10PM


4:25PM - 5:10PM Terrace Room Terrace Room
Terrace Room EXAMINING THE NECESSITY OF MEET THE EXPERTS: PANEL
PROTECTING YOURSELF FROM NEWER INSULINS FOR DISCUSSION WITH PLN FACULTY
HAZARDOUS DRUGS: IS YOUR IN-HOSPITAL DIABETES At the end of this presentation,
INSTITUTION FOLLOWING MANAGEMENT pharmacist participants should be
able to:
USP800? At the end of this presentation,
1. Discuss current evidence-based
At the end of this presentation, pharmacist participants should be
recommendations of the dis-
pharmacist participants should be able to:
cussed disease states towards
able to: 1. Describe the reasons for use
improving patient outcomes.
1. List the criteria utilized for de- of concentration insulin for-
2. Utilize contemporary medical
fining a hazardous drug. mulations in the treatment of
guidelines and strategies in the
2. Describe the criteria and meth- diabetes.
wide variety of medical disorders
odology used by NIOSH to iden- 2. Discuss the clinical, pharmaco-
presented.
tify drugs as hazardous. kinetic and pharmacodynamic
3. Explore new roles for health-sys-
3. Describe potential health risks profiles for current and emerging
tem pharmacists in our ever ex-
associated with exposure to basal insulins.
panding profession, as it relates
hazardous drugs. 3. Describe the pharmacist’s role
to direct patient care.
4. Explain strategies that employ in counseling patients from in-
Type of Activity: Knowledge-based
proper use of personal protective patient to outpatient settings to
0.5 contact hour (0.05 CEU)
equipment (PPE) and engineering minimize the risk of insulin-ad-
UAN: 0276-0000-16-034-L01-P
controls used to protect health- ministration errors and hospital
Randolph V. Fugit, PharmD, BCPS;
care personnel from exposure to readmissions.
Susan Cornell, PharmD, CDE,
hazardous drugs. At the end of this presentation, tech-
FAPhA, FAADE;
5. Describe components of a sur- nician participants should be able to:
Val R. Adams, PharmD, BCOP;
veillance program. 1. Describe the reasons for use
James S. Lewis II, PharmD, FIDSA
of concentration insulin for-
At the end of this presentation,
mulations in the treatment of
technician participants should be
diabetes.
able to: 6:15PM - 8:00PM
2. List the available formulations of
1. List the criteria utilized for de-
newer insulins. Crystal Rooms I & II
fining a hazardous drug.
3. Explain how to use an insulin HOUSE OF DELEGATES
2. Describe the criteria and meth-
pen.
odology used by NIOSH to iden-
Type of Activity: Knowledge-based
tify drugs as hazardous.
0.5 contact hour (0.05 CEU)
3. Describe potential health risks
UANs: 0276-0000-16-032-L01-P
associated with exposure to
0276-0000-16-032-L01-T
hazardous drugs.
Susan Cornell, PharmD, CDE,
4. Explain strategies that employ
FAPhA, FAADE
proper use of personal protective
equipment (PPE) and engineering
controls used to protect health-
care personnel from exposure to
hazardous drugs.
5. Describe components of a sur-
veillance program.
Type of Activity: Knowledge-based
0.75 contact hour (0.075 CEU)
UANs: 0276-0000-16-142-L01-P
0276-0000-16-142-L01-T
Christopher A. Fausel, PharmD,
BCPS, BCOP

12 2016 ICHP ANNUAL MEETING


Why work with us?
Because you care.
We are a company dedicated to human lives and to ensure
that each individual receives the care and compassion
they deserve. UNITED Pharmacy Staffing prides itself in
supplying only the most qualified pharmacy personnel
available for interim & permanent placement.
REGISTERED CERTIFIED OPERATIONAL
PHARMACISTS PHARMACY MANAGERS
TECHNICIANS
CLINICAL DIRECTOR OF
SPECIALISTS EXPERIENCED PHARMACY
PROJECT
MANAGERS

Call toll free (866) 321-7747 or visit www.upstaffing.com

BRINGING
FUTURES TOGETHER.
COLLEGE OF PHARMACY

For over 100 years, Rosalind Franklin University


has offered students exceptional clinical education,
research opportunities and exposure to emerging
technologies. The College of Pharmacy is pleased
to be a part of the University’s commitment to
interprofessional education. From day one, students
collaborate in teams, learning about, from, and with
other professions, and how, together, they each
impact the future of healthcare.
Learn more at www.rosalindfranklin.edu/cop

COLLEGE OF PHARMACY
rosalindfranklin.edu

More than 30 advanced medical and science degrees in metropolitan Chicago and online.
ICHP PHARMACY ACTION FUND CONTRIBUTORS
Advocacy Alliance - $2,500 - $10,000
Kevin Colgan James Owen Consulting, Inc. Scott Meyers Michael Weaver
Edward Donnelly Frank Kokaisl Michael Novario Thomas Westerkamp

Lincoln League - $1,000 - $2,499


Scott Bergman Ann Jankiewicz William McEvoy Avery Spunt
Andrew Donnelly Jan Keresztes Christina Quillian JoAnn Stubbings
Ginger Ertel Kathy Komperda Michael Rajski Patricia Wegner
Linda Fred Despina Kotis Carrie Sincak

Capitol Club - $500 - $999


Margaret Allen Kenneth Foerster Janette Mark Kathryn Schultz
Sheila Allen Leonard Kosiba Mary Lynn Moody Heidi Sunday
Rauf Dalal Mary Lee Jennifer Phillips Jill Warszalek
Drury Lane Theatre George MacKinnon Edward Rainville

General Assembly Guild - $250 - $499


Tom Allen Scott Drabant Travis Hunerdosse Peggy Reed
Jennifer Arnoldi Brad Dunck Kim Janicek Tara Vickery Gorden
Peggy Bickham Nancy Fjortoft Ronald Miller Carrie Vogler
Jaime Borkowski Jo Ann Haley Karen Nordstrom Marie Williams

Springfield Society - $100 - $249


Jill Borchert Lara Ellinger Dylan Marx Jerry Storm
Noelle Chapman Jennifer Ellison Milena McLaughlin Brandi Strader
Kathy Cimakasky Joan Hardman Katherine Miller Amanda Wolff
Christopher Crank Charlene Hope James Sampson

Grassroots Gang - $50 - $99


Katrina Althaus Erika Hellenbart Bill Middleton Nadia Tancredi
Rebecca Castner Bella Maningat Mark Moffett
Megan Hartranft Brian Matthews Gary Peksa

Contributor - $1 - $49
Marc Abel Josh DeMott Josie Klink David Silva
Tamkeen Abreu Janet Engle Connie Larson Helen Sweiss
Trisha Blassage Linda Grider Barbara Limburg-Mancini Steve Tancredi
Colleen Bohnenkamp Heather Harper David Martin Karin Terry
Skylar Boldue Ina Henderson Michelle Martin Tom Wheeler
Jeremy Capulong Antoine Jenkins Natalie Schwarber Matt Zhang
Antoinette Cintron Levi Karell Pilones Sarah Sheley

TO CONTRIBUTE ONLINE NOW OR PRINT A MAIL-IN FORM, go to ichpnet.org, use the main menu navigate to
Pharmacy Practice > Advocacy > Pharmacy Action Fund (PAC) > Contribute to PAC.
At Bristol-Myers Squibb, we are
working together for patients.

Our mission is clear — we discover,


develop and deliver transformational
medicines that help people prevail
over serious diseases.

Our sense of urgency is real — we work


every day to push the boundaries
of scientific discovery and to make
a meaningful difference in the lives
of patients.

It’s what we do. It’s why we do it.

www.bms.com

© 2016 Bristol-Myers Squibb Company

ICHP Annual Meeting ad.indd 1 8/8/16 11:34 AM


FRIDAY, SEPTEMBER 16

7:00AM - 8:00AM 9:00AM - 10:00AM


FRIDAY Foyer Terrace & Venetian Rooms
AT-A-GLANCE CONTINENTAL BREAKFAST I LOVE YOU, I LOVE YOU NOT:
REFLECTIONS ON THE PAST,
7:00AM - 5:45PM GENERAL SESSION PRESENT AND FUTURE
ICHP REGISTRATION DESK HOURS 8:00AM - 9:00AM RELATIONSHIP BETWEEN
Foyer
Terrace & Venetian Rooms
PHARMACY AND THE
PHARMACEUTICAL INDUSTRY
7:00AM - 8:00AM OPIOID MISUSE: THE
At the end of this presentation,
CONTINENTAL BREAKFAST EVOLUTION OF AN EPIDEMIC
Foyer pharmacist participants should be
At the end of this presentation, able to:
pharmacist participants should be
8:00AM - 10:00AM able to:
1. Describe the evolution of the
GENERAL SESSION pharmaceutical industry and
1. Explain the scope and impact its relationship with health
Terrace & Venetian Rooms
of the U.S. opioid epidemic. care professionals (emphasis
2. Outline state and federal ef-
8:00AM - 10:00AM forts to support safe and effec-
on pharmacists and pharmacy
REVERSE EXHIBIT technicians) and patients.
tive treatment of pain, while 2. Explain the pharmaceutical in-
(invitation only)
reducing opioid use disorders. dustry’s paradigm shift from
Crystal Room
3. Describe how pharmacists can patient-centered to profit-cen-
be involved in curbing the opi-
10:00AM - 12:00PM oid epidemic.
tered and the reasons for it.
EXHIBIT PROGRAM & RECEPTION 3. Identify current issues related
4. List resources for pharmacists, to the industry-pharmacy-pa-
Oak & Brook Rooms
technicians, and patients for tient triad, including drug pric-
pain management and opioid
12:00PM - 1:00PM abuse.
ing, direct to consumer adver-
LUNCH & TOWN HALL MEETING tising, drug shortages, etc.
At the end of this presentation, 4. Discuss the differences in the re-
Terrace & Venetian Rooms
technician participants should be lationship between pharmacists
able to:
1:15PM - 2:40PM 1. Explain the scope and impact
and the pharmaceutical indus-
KEYNOTE SESSION try in the 1970s and the present.
of the U.S. opioid epidemic. At the end of this presentation,
Terrace & Venetian Rooms
2. Outline state and federal ef- technician participants should be
forts to support safe and effec-
2:45PM - 5:45PM tive treatment of pain, while
able to:
TRACK 1 – PHARMACY 1. Describe the evolution of the
reducing opioid use disorders. pharmaceutical industry and
TECHNOLOGY SESSION
3. Describe how pharmacy tech- its relationship with health
Crystal Room
nicians can be involved in curb- care professionals (emphasis
ing the opioid epidemic.
2:45PM - 5:45PM 4. List resources for pharmacists,
on pharmacists and pharmacy
TRACK 2 – CLINICAL SESSION technicians) and patients.
technicians, and patients for 2. Explain the pharmaceutical in-
Terrace & Venetian Rooms
pain management and opioid dustry’s paradigm shift from
abuse.
5:45PM - 7:00PM Type of Activity: Knowledge-based
patient-centered to profit-cen-
NPN MIXER tered and the reasons for it.
1.0 contact hour (0.1 CEU) 3. Identify current issues related
Foyer
UANs: 0121-0000-16-064-L03-P to the industry-pharmacy-pa-
0121-0000-16-064-L03-T
7:00PM - 9:30PM Carrie Vogler, PharmD, BCPS
tient triad, including drug pric-
PRESIDENT’S DINNER ing, direct to consumer adver-
(invitation only) tising, drug shortages, etc.
Reel Club 4. Discuss the differences in the re-
lationship between pharmacists
and the pharmaceutical indus-
try in the 1970s and the present.
Type of Activity: Knowledge-based
1.0 contact hour (0.1 CEU)
UANs: 0121-0000-16-065-L04-P
16 2016 ICHP ANNUAL MEETING 0121-0000-16-065-L04-T
Henri R. Manasse, Jr., PhD, ScD, FFIP
FRIDAY, SEPTEMBER 16

8:00AM - 10:00AM KEYNOTE SESSION


Crystal Room 1:15PM - 2:40PM
REVERSE EXHIBIT Terrace & Venetian Rooms
(invitation only) LEADERSHIP THROUGH THE
RANKS
At the end of this presentation,
10:00AM - 12:00PM pharmacist participants should be
Oak & Brook Rooms able to:
EXHIBIT PROGRAM & RECEPTION 1. Recognize how personal lead-
ership starts at the beginning
and continues throughout
one’s career.
10:00AM - 12:00PM 2. Clarify the difference between
Foyer “leadership” and “management”.
VISIT THE ICHP BEST PRACTICE 3. Relate personal leadership to
decision making, productivity,
AWARD WINNER team work and achieving per-
ABOUT JACK HARRIS . . .
sonal & professional goals.
4. Recognize the connection to Jack conducts training on a variety
12:00PM - 1:00PM customer service (both internal of topics aimed at Helping Keep
Good People Good. People from
Terrace & Venetian Rooms and external).
professional associations, large &
5. Identify obstacles to demon-
LUNCH & TOWN HALL MEETING strating personal leadership.
small businesses, non-profit orga-
nizations, the health care industry,
At the end of this presentation, government agencies and public
technician participants should be safety organizations have benefitted
able to: from his insightful understanding of
1. Recognize how personal lead- human nature & behavior, manage-
ership starts at the beginning ment experience and behavioral sci-
and continues throughout ence background. His presentations
one’s career. revolve around personal resilience,
management & supervisory train-
2. Clarify the difference between
ing, interpersonal skills and response
“leadership” and “management”. to trauma & crisis and offer use-
3. Relate personal leadership to ful information, not just theory and
decision making, productivity, trendy “buzz-words.” Regardless of
team work and achieving per- the topic, Jack’s aim is to help people
sonal & professional goals. develop practical skills they can ap-
4. Recognize the connection to ply to everyday, real-life situations.
customer service (both internal
and external). Jack is a Licensed Professional Coun-
5. Identify obstacles to demon- selor (by the Arizona Board of Be-
havioral Health Examiners), trained
strating personal leadership.
mediator, Board Certified Expert in
Type of Activity: Knowledge-based Traumatic Stress by the American
1.5 contact hours (0.15 CEUs) Academy of Experts in Traumatic
UANs: 0121-0000-16-066-L04-P Stress and an approved instructor
0121-0000-16-066-L04-T for the International Critical Incident
Jack Harris, MEd, LPC Stress Foundation. He spent twenty
years with the Tucson, Arizona Police
Department; where he held a wide
variety of administrative and opera-
tional executive-level positions. He
holds a Master’s Degree from the
University of Arizona and a Bach-
elor’s Degree from Western Illinois
University.

LEADERSHIP: IT’S NOT JUST FOR LEADERS! 17


FRIDAY, SEPTEMBER 16

TRACK 1 – PHARMACY 5. Describe potential solutions 4:00PM - 5:00PM


TECHNOLOGY SESSION that minimize complications Crystal Room
2:45PM - 3:45PM and maximize chances for suc-
USING TECHNOLOGY TO
cess with automated device
Crystal Room ADDRESS SEPSIS
standardization.
INFORMATICS PEARLS Type of Activity: Knowledge-based At the end of this presentation,
• ILLINOIS PRESCRIPTION 1.0 contact hour (0.1 CEU) pharmacist participants should be
MONITORING PROGRAM UANs: 0121-0000-16-067-L04-P able to:
0121-0000-16-067-L04-T 1. Review the use of technology
• FORMULARY Joshua Hartman, PharmD, MS in the management of sepsis.
STANDARDIZATION Health Informatics; 2. Describe screening for the sep-
• DRUG DIVERSION Deanna Horner, PharmD, BCPS; sis patient population in order
MONITORING Vern L. Johnson, BS Pharm; to provide early identification.
Brian Le, PharmD 3. Explain steps for antimicrobial
• AUTOMATED DISPENSING surveillance.
CABINET STANDARDIZATION 4. Discuss how the technology is
At the end of this presentation, 3:45PM - 4:00PM operationalized to activate a
pharmacist participants should be multidisciplinary team includ-
Foyer
able to: ing pharmacy.
1. Define the benefits of direct inte- BREAK At the end of this presentation,
gration with the Illinois Prescrip- technician participants should be
tion Monitoring Program with an able to:
Electronic Health Record. 1. Review the use of technology
2. List steps to consider when in the management of sepsis.
standardizing the formulary 2. Describe screening for the sep-
across departments, hospitals sis patient population in order
and/or health systems. to provide early identification.
3. Recognize diversion opportu- 3. Explain steps for antimicrobial
nities and identify tools for surveillance.
prevention and detection. 4. Discuss how the technology is
4. Explain the challenges involved operationalized to activate a
with automated device stan- multidisciplinary team includ-
dardization. ing pharmacy.
5. Describe potential solutions Type of Activity: Knowledge-based
that minimize complications 1.0 contact hour (0.1 CEU)
and maximize chances for suc- UANs: 0121-0000-16-068-L04-P
cess with automated device 0121-0000-16-068-L04-T
standardization. Heather M. Harper, PharmD,
At the end of this presentation, BCPS;
technician participants should be Brian Le, PharmD;
able to: Elise M. Wozniak, PharmD
1. Define the benefits of direct inte-
gration with the Illinois Prescrip-
tion Monitoring Program with an
Electronic Health Record.
2. List steps to consider when
standardizing the formulary
across departments, hospitals
and/or health systems.
3. Recognize diversion opportuni-
ties and identify tools for pre-
vention and detection.
4. Explain the challenges involved
with automated device stan-
dardization.

18 2016 ICHP ANNUAL MEETING


FRIDAY, SEPTEMBER 16

5:00PM - 5:45PM TRACK 2 – CLINICAL SESSION 4:00PM - 5:00PM


Crystal Room 2:45PM - 3:45PM Terrace & Venetian Rooms
STANDARDIZATION ACROSS Terrace & Venetian Rooms VENOUS THROMBOEMBOLISM
THE ENTERPRISE UNDERSTANDING RECENT MANAGEMENT: BRIDGING THE
At the end of this presentation, ADVANCES IN PAH GAP BETWEEN INPATIENT AND
pharmacist participants should be MANAGEMENT: A PRACTICAL OUTPATIENT
able to:
1. Define processes to achieve
GUIDE FOR CLINICAL At the end of this presentation,
PHARMACISTS pharmacist participants should be
and maintain standardization
able to:
across enterprise for medica- At the end of this presentation,
1. Compare and contrast the up-
tion use in the EHR and other pharmacist participants should be
dated CHEST Guideline and Ex-
technologies. able to:
pert Panel Report for preven-
2. Identify considerations when 1. Utilize evidence-based treat-
tion and treatment of venous
implementing and maintain- ment algorithms to guide ther-
thromboembolism to previous
ing standardized enterprise apeutic approaches for PAH
CHEST guidelines.
formulary. based on disease classification
2. Discuss the recently published
3. Recognize areas where stan- and prognostic factors.
Anticoagulation Forum guid-
dardized enterprise formu- 2. Evaluate the role of the various
ance document on venous
lary cross with information therapeutic classes, as mono-
thromboembolism and its im-
technology. therapy or combination thera-
pact on clinical practice.
At the end of this presentation, py, in the treatment of PAH as
3. Design optimal inpatient to out-
technician participants should be a means to individualize ther-
patient transitions of care for
able to: apy based on disease severity
patients with venous thrombo-
1. Define processes to achieve and patient factors.
embolism.
and maintain standardization 3. Discuss the role of pharmacists
At the end of this presentation,
across enterprise for medica- as part of the multiprofessional
technician participants should be
tion use in the EHR and other healthcare team in ensuring
able to:
technologies. the safe and effective use of
1. List recommendations in the
2. Identify considerations when PAH medications.
updated CHEST Guideline and
implementing and maintain- Type of Activity: Knowledge-based
Expert Panel Report for pre-
ing standardized enterprise 1.0 contact hour (0.1 CEU)
vention and treatment of ve-
formulary. UAN: 0473-9999-16-004-L01-P
nous thromboembolism.
3. Recognize areas where stan- Rebekah L. Hanson, PharmD,
2. Discuss the recently published
dardized enterprise formu- BCPS, BCACP
Anticoagulation Forum guid-
lary cross with information
This activity is jointly provided ance document on venous
technology.
by Center for Independent thromboembolism and its im-
Type of Activity: Knowledge-based
Healthcare Education and Vemco pact on clinical practice.
0.75 contact hour (0.075 CEU)
MedEd; and is supported by 3. Define optimal inpatient to out-
UANs: 0121-0000-16-069-L04-P
educational grants from patient transitions of care for
0121-0000-16-069-L04-T
Actelion Pharmaceuticals and patients with venous thrombo-
Michelle Geurink, RPh
United Therapeutics. embolism.
For full program information, Type of Activity: Application-based
please go to http://www.ichpnet. 1.0 contact hour (0.1 CEU)
org/events/annual_meeting/2016/ UAN: 0121-0000-16-070-L01-P
PAH_Flyer_ICHP.pdf. Type of Activity: Knowledge-based
1.0 contact hour (0.1 CEU)
UAN: 0121-0000-16-071-L01-T
3:45PM - 4:00PM Diana Isaacs, PharmD, BCPS, BC-
ADM, CDE;
Foyer
Alexander Kantorovich, PharmD,
BREAK BCPS

LEADERSHIP: IT’S NOT JUST FOR LEADERS! 19


FRIDAY, SEPTEMBER 16

5:00PM - 5:45PM
Terrace & Venetian Rooms
NEW ANTIBIOTICS FOR THE
POST-ANTIBIOTIC ERA
At the end of this presentation,
pharmacist participants should be
able to:
1. Review recently approved anti-
microbials including their spec-
trum of activity and potential
place in therapy.
2. Discuss the pertinent antimicro-
bial stewardship implications of
newly approved agents.
3. Identify antimicrobial agents
in the advanced stages of the
drug development pipeline and
assess their potential implica-
tions for infectious diseases
pharmacotherapy.
At the end of this presentation,
technician participants should be
able to:
1. Review recently approved anti-
microbials including their spec-
trum of activity and potential
place in therapy.
2. Discuss the pertinent antimicro-
bial stewardship implications of
newly approved agents.
3. Identify antimicrobial agents
in the advanced stages of the
drug development pipeline.
Type of Activity: Knowledge-based
0.75 contact hour (0.075 CEU)
UANs: 0121-0000-16-072-L01-P
0121-0000-16-072-L01-T
Eric Wenzler, PharmD

5:45PM - 7:00PM
Foyer ICHP has a NEW
NPN MIXER
Ambulatory Care Network!
Bryan McCarthy and Ginny Nash, Co-Chairs.
7:00PM - 9:30PM
Reel Club
PRESIDENT’S DINNER Interested?
(invitation only) Let us know at 815-227-9292.

20 2016 ICHP ANNUAL MEETING


NPN Mixer
FRIDAY, SEPTEMBER 16
5:45 - 7:00PM
FOYER

Thursday, September 15
through 11:00AM on
Saturday, September 17
Orchestrate a Masterful Performance with Omnicell
Healthcare facilities worldwide have implemented Omnicell medication automation to maximize
efficiency, improve supply chain management, and effectively address drug diversion and regulations.
Now we’ve expanded our repertoire, giving you more options to advance
medication management—from hospital to home:

• Robotic pharmacy dispensing systems


• IV compounding automation
• Automated dispensing cabinets
• Medication adherence solutions
• Analytics for inventory and clinical insights

Omnicell — Bringing harmony to your pharmacy.

Omnicell, Inc. • Mountain View, CA • Tel: 800.850.6664 or 650.251.6100 • www.omnicell.com

ICHP_Ad_08_16.indd 1 8/9/16 4:58 PM


SATURDAY, SEPTEMBER 17

7:30AM - 8:00AM 9:15AM - 9:30AM


SATURDAY Foyer Foyer
AT-A-GLANCE CONTINENTAL BREAKFAST BREAK

7:30AM - 3:15PM TRACK 1 – TECHNICIAN SESSION


ICHP REGISTRATION DESK HOURS 8:00AM - 9:15AM 9:30AM - 10:30AM
Foyer English Room
English Room
CULTIVATING SAFETY IN THE
7:30AM - 8:00AM PHARMACY AUDITS – HOW
CONTINENTAL BREAKFAST CAN THE PHARMACY STAFF PHARMACY
Foyer At the end of this presentation,
GET INVOLVED?
pharmacist participants should be
8:00AM - 11:30AM At the end of this presentation, able to:
TRACK 1 – TECHNICIAN SESSION pharmacist participants should be 1. Describe the link between just
English Room able to: culture and error prevention.
1. Review main Joint Commis- 2. Recognize the culpability of
8:00AM - 11:30AM sion and 340B Medication various types of errors.
TRACK 2 – PHARMACY Management standards and 3. Order the effectiveness of pro-
PRACTICE SESSION requirements. cess improvement strategies
Crystal Room 2. Outline the preparatory pro- from most to least effective.
cess and identify strategies for 4. Identify techniques to improve
8:00AM - 11:30AM successful TJC and 340B audits. “high-stakes” communication.
TRACK 3 – STUDENT SESSION 3. Discuss potential roles phar- At the end of this presentation,
Venetian Room macy technicians can play in technician participants should be
preparation for an audit. able to:
11:30AM - 1:00PM 4. Recognize how the “lessons 1. Describe the link between just
LUNCH & AWARDS PROGRAM learned” from the audit can be culture and error prevention.
Terrace Room used to improve compliance 2. Recognize the culpability of
with the set standards. various types of errors.
1:00PM - 3:00PM At the end of this presentation, 3. Order the effectiveness of pro-
CLOSING GENERAL SESSION technician participants should be cess improvement strategies
Crystal Room able to: from most to least effective.
1. Review main Joint Commis- 4. Identify techniques to improve
1:00PM - 3:00PM sion and 340B Medication “high-stakes” communication.
RESIDENCY SHOWCASE Management standards and Type of Activity: Knowledge-based
Oak & Brook Rooms requirements. 1.0 contact hour (0.1 CEU)
2. Outline the preparatory pro- UANs: 0121-0000-16-074-L05-P
cess and identify strategies for 0121-0000-16-074-L05-T
successful TJC and 340B audits. Adam Bursua, PharmD, BCPS
3. Discuss potential roles phar-
macy technicians can play in
preparation for an audit.
4. Recognize how the “lessons
learned” from the audit can be
used to improve compliance
with the set standards.
Type of Activity: Knowledge-based
1.25 contact hours (0.125 CEUs)
UANs: 0121-0000-16-073-L04-P
0121-0000-16-073-L04-T
Sima Shah, PharmD, MPH;
Thomas Wheeler, PharmD, BCPS,
CPHIMS

LEADERSHIP: IT’S NOT JUST FOR LEADERS! 23


SATURDAY, SEPTEMBER 17

10:30AM - 11:00AM 11:00AM - 11:30AM TRACK 2 – PHARMACY


English Room English Room PRACTICE SESSION
THE EXPANDING ROLE OF PHARMACY 8:00AM - 9:15AM
PHARMACY TECHNICIANS – TECHNICIAN-ACQUIRED Crystal Room
INVESTIGATIONAL DRUG SERVICE MEDICATION HISTORIES IN THE RESIDENCY PROJECT PEARLS
At the end of this presentation, ED – A PATH TO HIGHER • THE IMPACT OF
pharmacist participants should be QUALITY OF CARE IMPLEMENTING A ß-LACTAM
able to: ALLERGY GUIDELINE AT A
At the end of this presentation,
1. Review goals and structure
of the Investigational Drug
pharmacist participants should be LARGE ACADEMIC MEDICAL
able to: INSTITUTION
Service (IDS).
1. Identify opportunities for ex-
2. Review Good Clinical Practice
panded pharmacy technician
• PREFERENCES FOR PATIENT
(GCP) and other guidelines. MEDICATION LIST STRUCTURE
roles in obtaining accurate,
3. Identify IDS technician respon-
sibilities and job requirements.
timely medication histories in TO OPTIMIZE UTILIZATION
the emergency department. • OPTIMIZING MEDICATION
At the end of this presentation,
2. Describe the components and
technician participants should be
value of a pharmacy techni- BATCHING SCHEDULES IN
able to:
cian driven medication his- ORDER TO REDUCE
1. Review goals and structure
of the Investigational Drug
tory program. MEDICATION WASTE IN A
At the end of this presentation,
Service (IDS). PEDIATRIC SETTING
technician participants should be
2. Review Good Clinical Practice At the end of this presentation,
able to:
(GCP) and other guidelines. pharmacist participants should be
1. Identify opportunities for ex-
3. Identify IDS technician respon- able to:
panded pharmacy technician
sibilities and job requirements. 1. Recognize the true cross-reactiv-
roles in obtaining accurate,
Type of Activity: Knowledge-based ity between penicillins, cephalo-
timely medication histories in
0.5 contact hour (0.05 CEU) sporins, and carbapenems in ß-
the emergency department.
UANs: 0121-0000-16-075-L04-P lactam allergic patients.
2. Describe the components and
0121-0000-16-075-L04-T 2. Identify patients with reported
value of a pharmacy techni-
Margarita Villarreal-Flores, CPhT ß-lactam allergies who can safe-
cian driven medication his-
tory program. ly tolerate ß-lactam antibiotics.
Type of Activity: Knowledge-based 3. Identify barriers to medication
0.5 contact hour (0.05 CEU) list utilization for physicians and
UANs: 0121-0000-16-076-L04-P other healthcare professionals.
0121-0000-16-076-L04-T 4. Describe preliminary pilot data
David Huhtelin, PharmD on understanding patient utili-
zation of their medication list.
5. Describe lean methodology
processes and how they can be
applied to pharmacy workflow.
6. Identify factors specific to the
inpatient pediatric setting that
can contribute to increased
medication waste.
Type of Activity: Knowledge-based
1.25 contact hours (0.125 CEUs)
UAN: 0121-0000-16-077-L04-P
Michael Beshir, PharmD;
Anne Misher, PharmD;
Jasmine Shah, PharmD

24 2016 ICHP ANNUAL MEETING


SATURDAY, SEPTEMBER 17

9:15AM - 9:30AM TRACK 3 – STUDENT SESSION 1:00PM - 3:00PM


Foyer 8:00AM - 11:30AM Oak & Brook Rooms
BREAK Venetian Room RESIDENCY SHOWCASE
THE VIBRANT SHUFFLE ON THE
PATH TO A RESIDENCY: GETTING
9:30AM - 11:30AM THE INSIDE LOOK AT THE CLOSING GENERAL SESSION
Crystal Room PROCESS AND PEOPLE 1:00PM - 2:00PM
INNOVATIVE PHARMACY INVOLVED Crystal Room
SERVICES: BOLDLY GOING • KEY TO A TOP CURRICULUM PEACE, LOVE, AND
VITAE AND LETTER OF INTENT
WHERE NO PHARMACIST HAS UNDERSTANDING LEADERSHIP
• GENERAL PGY-1 INFO: WHAT
GONE BEFORE ARE YOUR OPTIONS IN At the end of this presentation,
• PHARMACISTS WALKING ON AMBULATORY CARE AND pharmacist participants should be
HOSPITAL? able to:
NEW TERRITORY TO SAVE 1. Discuss strategies for success-
• GETTING READY TO BE
LIMBS: THE COLLABORATION INTERVIEWED AND HOW TO fully integrating life and career.
BETWEEN PHARMACISTS CONDUCT YOURSELF AT THE 2. List barriers to recruiting and re-
AND PODIATRISTS MIDYEAR/SHOWCASE taining women leaders as well as
• THE MATCH PROCESS AND solutions to these barriers.
• CLINICAL PHARMACY 3. Describe examples of mentors
PHORCAS
SERVICES IN A DENTAL • GET THE INSIDE SCOOP FROM versus sponsors and the differ-
MEDICINE CLINIC: AN A RESIDENCY PRECEPTOR ences between them.
• GET THE INSIDE SCOOP FROM 4. Discuss gender differences in
INNOVATION AND DYNAMIC
A RESIDENT leadership and how to success-
INTERPROFESSIONAL TEAM fully incorporate into manage-
Jennifer H. Austin-Szwak, PharmD;
At the end of this presentation, Kristin Bradley, PharmD; ment style.
pharmacist participants should be Noelle Chapman, PharmD, BCPS; At the end of this presentation,
able to: Jennifer C. Ellison, PharmD, BCPS; technician participants should be
1. Examine the role of the pharma- Katie Gauen, PharmD; able to:
cist in collaborative care clinics. Luke Hvass, PharmD; 1. Discuss strategies for success-
2. Discuss the development of Nadine Isho, PharmD; fully integrating life and career.
a pharmacy consult services Abby A. Kahaleh, BS Pharm, MS, 2. List barriers to recruiting and re-
within interprofessional sites. PhD, MPH; taining women leaders as well as
3. Explore methods to enhance Karen M. Kelly, PharmD; solutions to these barriers.
student learning in a collabora- Christopher Leong, PharmD; 3. Describe examples of mentors
tive setting. Milena McLaughlin, PharmD, versus sponsors and the differ-
4. Identify metrics used to track MSc, BCPS, AAHIVP; ences between them.
the impact of collaborative ef- Frank Paloucek, PharmD, DABAT, 4. Discuss gender differences in
forts on patient outcomes. FASHP; leadership and how to success-
Type of Activity: Knowledge-based Jennifer Phillips, PharmD, BCPS; fully incorporate into manage-
2.0 contact hours (0.2 CEUs) Molly Rockstad, PharmD, BCPS, ment style.
UAN: 0121-0000-16-078-L04-P BCACP; Type of Activity: Knowledge-based
Julio Rebolledo, PharmD, BCPS, Sheila Wang, PharmD, BCPS AQ-ID 1.0 contact hour (0.1 CEU)
AE-C; UANs: 0121-0000-16-079-L04-P
Student session is not accredited.
Lisa Palmisano, PharmD, BCACP; 0121-0000-16-079-L04-T
Jennifer Mazan, PharmD Desi Kotis, PharmD, FASHP;
Panel:
11:30AM - 1:00PM Erick Borkowski, PharmD;
Whitnee Caldwell, PharmD;
Terrace Room Sharon Karina, PharmD Candidate
LUNCH & AWARDS PROGRAM

LEADERSHIP: IT’S NOT JUST FOR LEADERS! 25


SATURDAY, SEPTEMBER 17

2:00PM - 3:00PM
Crystal Room
NEW DRUGS 2016
At the end of this presentation,
pharmacist participants should be
able to:
1. Describe the place in therapy
and mechanisms of action of
newly approved drugs in the
last 15 months.
2. Compare newly approved agents
from current agents utilized in
the management of disease.
3. Describe newly approved
agents in terms of their place in
therapy, effectiveness, safety,
and patient administration.
4. Summarize important patient
counseling pearls for newly ap-
proved agents for the manage-
ment of disease.
At the end of this presentation,
technician participants should be
able to:
1. Describe the place in therapy
and mechanisms of action of
newly approved drugs in the
last 15 months.
2. Compare newly approved agents
from current agents utilized in
the management of disease.
3. Describe newly approved
agents in terms of their place in
therapy, effectiveness, safety,
and patient administration.
Type of Activity: Knowledge-based
1.0 contact hour (0.1 CEU)
UANs: 0121-0000-16-080-L01-P
0121-0000-16-080-L01-T
Diana Isaacs, PharmD, BCPS, BC-
ADM, CDE;
Lalita Prasad-Reddy, PharmD,
MS, BCPS, BCACP, CDE

Be social with us!


facebook.com/ichpnet twitter.com/ichpnet youtube.com/user/ichpnet

26 2016 ICHP ANNUAL MEETING


Champions Program
Don’t have an ICHP Champion at your work site?
Please consider volunteering to be a Champion! Jennifer Splawski
ICHP Champion at
Champions serve as a point person for ICHP CPE live
MacNeal Hospital
webinar programs offered bi-monthly, and post News
Berwyn, IL
Briefs on important legislative issues, ICHP events and
networking opportunities.
"I think it’s very important to
Contact Trish Wegner at TrishW@ichpnet.org if you are give back to the profession.
interested! When I was a student, I had
fabulous mentors who made
Champions Program Participating Sites me who I am today. I wanted
Advocate Christ Medical Center OSF St. Anthony Medical Center to give back to the profession
Advocate Good Samaritan Hospital OSF St. Francis Medical Center in the same way that my men-
Advocate Lutheran General Hospital OSF St. Francis Medical Center
Advocate South Suburban Hospital OSF St. Joseph Medical Center tors did. In addition, by being
ALMH OSF St. Mary Medical Center part of a professional organi-
Ann Kiley Center Palos Community Hospital
Carle Foundation Hospital Pekin Hospital
zation, we have an opportuni-
Centegra Woodstock Hospital Premier Inc. ty to create change. It is easier
Chicago State University Presence Mercy Medical Center to create change with a body
FHN Memorial Hospital Presence St. Joseph Medical Center
Graham Hospital Presence United Samaritans of like-minded people than it
Hamilton Memorial Hospital Medical Center is as an individual. Lastly, net-
Hines VA Hospital RML Specialty Hospital
HSHS St. John's Hospital Roosevelt University College of Pharmacy
working is also important in
HSHS St. Mary's Hospital Rush University Medical Center pharmacy. Opportunities are
John H. Stroger Hospital SIUE School of Pharmacy not as plentiful as they once
Kishwaukee Hospital Skokie Hospital
KSB Hospital St. Elizabeth Hospital were and networking with
Lovell Federal Health Care Center St. Anthony Medical Center people who have more expe-
Loyola University Medical Center St. Bernard Hospital
Lurie Children's Hospital of Chicago St. John's Hospital
rience than you can provide
MacNeal Hospital SwedishAmerican Hospital countless opportunities."
Marianjoy Rehabilitation Hospital Swedish Covenant Hospital
Memorial Hospital Talent First, PBC
Memorial Medical Center UIC College of Pharmacy
Mercy Hospital & Medical Center UIC Hospital - Inpatient
MercyRockford Health System UIC Hospital - Outpatient
(Rockford Memorial) University of Chicago Medicine
Mount Sinai Hospital VA Medical Center
NorthShore University HealthSystem
Northwestern Memorial Hospital
Norwegian American Hospital
Oak Park Hospital
CPE CREDIT INSTRUCTIONS
These are the instructions for obtaining CPE credit for ICHP accredited courses.

Please NOTE: You MUST complete your evaluation submissions by end of day Monday, October 31, 2016.

Please READ all information carefully so you understand the deadlines and how to access credit statements.
After the meeting, all attendees will need to access ICHP’s online CPE system at CESally.com, and complete
and submit all evaluations to have your credit automatically submitted to CPE Monitor.
Please honor the ICHP deadlines! Do NOT Delay in completing your CPE processing. If you encounter
problems, we will need time to assist you before the final deadline.
To obtain CPE credit for each ICHP accredited course attended, attendees must complete the follow-
ing requirements. (Please note: To receive CIHE and/or NACCME credit, you must follow the directions
provided in their respective handouts.)

QUICK OVERVIEW
1. Fill out your CPE Attendance Record (2-part white and yellow form in folder) during sessions.
2. Turn in BOTH the White and Yellow copy and your Audience Response device at Registration check out.
3. Registration attendant signs BOTH copies and keeps the White top copy. Please SAVE your yellow copy!
4. Go to CESally.com and Login if you have an account; or “Sign Up!” to create an account if new to the
site. Important! You must enter your NABP eProfile ID & birthdate as MMDD to set up your account
and get credit.
5. Use the Search function to find all the Program Titles you attended and Add to your To-do List.
6. Go to your To-do List to complete program evaluations and submit. Follow the directions.
7. Once completed, you will see a submission confirmation message.
8. Go to your CPE Monitor account at NABP.net to print off official transcripts or statements of credit.

DETAILED STEPS ON HOW TO COMPLETE THE EVALUATION PROCESS –


Session Access Codes will be announced by the moderators during each session – write the codes on your
“CPE Attendance Record” sheet (2-part white and yellow form). Please fill in your “Name” information on
your CPE Attendance Record. At the end of your participation at the conference, please turn in BOTH the
white copy of your CPE Attendance Record, and your Audience Response device at the Registration Desk.
Registration attendants sign both copies, and keep the white copy. You will get the yellow copy back. Keep
the yellow copy of the CPE Attendance Record for your file as you will need the Session Codes in order to
complete the process of receiving your CPE credit.

DETAILED INSTRUCTIONS TO COMPLETE EVALUATIONS ONLINE:


1. Go to www.CESally.com and click on “Sign Up!” Or log in with your existing account. For HELP at any
point, click on the HELP tab or go to: https://www.cesally.com/help/.
2. Complete the Sign Up process and select a username and password.
Important: Please store your username and password in a safe place. You will need to maintain a valid
email address with CESally.com.
3. Enter your NABP eProfile ID and birthdate as MMDD when prompted. CESally.com will confirm in real
time your eProfile information with CPE Monitor and let you know if there is an error, which you may
then correct.

28 2016 ICHP ANNUAL MEETING


4. Once you have an account, you may use the Search Box in the upper right corner to find a single activ-
ity by typing in the title, OR type in "2016 ICHP Annual Meeting", to see all meeting sessions. You have
several options for completing or saving for later.

Please pay CLOSE attention to the Title and the Pharmacist or Technician label at the end of each title.
PHARMACISTS: You may NOT receive credit for Technician programs.
TECHNICIANS: As of January 1, 2015, PTCB requires Technicians use only Technician-specific CPE credit
to recertify.
5. Identify the program(s) attended and choose either to:
a) Click on that Activity title to open the information page, and you will see your options in the right
hand column on the information page.

b) OR Click on the checkbox inside the small information box, then go to the bottom of the page and see
your options there.

6. Choose from either a) or b) above, to Complete Now, Save for Later, OR ADD to To-do List.
7. When you are ready to complete your CPE credit process, follow directions to EVALUATE the programs.
• You will verify your attendance, provide the session ACCESS code that was given to you during the
program, and complete an evaluation of the activity and the speaker(s).
8. Click on “Report CE”. Your CPE credit will be uploaded to CPE Monitor automatically. You will see a
submission confirmation message when you have successfully completed the process.
9. If you have any questions contact us at members@ichpnet.org.
10. Go to www.NABP.net to download an official copy of your CPE transcripts. Click on the CPE Monitor link
and log in to access your CPE Monitor records.

Important: Per ACPE requirements, official transcripts and statements of credit may now be accessed
ONLY through CPE Monitor.

PLEASE Note: You will have until the end of day Monday, October 31, 2016 to complete your online evalua-
tion and submit it for your CPE credit. ICHP policy requires that CPE evaluations be completed within a specific
deadline to ensure timely submission of your CPE credit to your CPE Monitor account, and to meet the ACPE
deadlines. Anything submitted after the ACPE deadlines will be rejected by CPE Monitor. If you miss the dead-
line you will lose your credit.

Remember – if you experience any problems, we will need time to assist you. Please do not delay!

Important Notice: Only registered attendees to the CPE presentations are eligible to receive credit.
Meeting registration lists and CPE attendance records are used to verify that those who process credit
on CESally.com attended the live programming. Any discrepancies will be reviewed for possible action
in accordance with ACPE and Board of Pharmacy standards and policies.

LEADERSHIP: IT’S NOT JUST FOR LEADERS! 29


FACULTY & DISCLOSURES

It is the policy of the Illinois Council of Health-System Pharmacists to ensure balance, objectivity, and
scientific rigor in all their individually or jointly presented continuing education programs. All faculty
participating in any Illinois Council of Health-System Pharmacists’ continuing education programs
are expected to disclose any real or apparent conflict(s) of interest that may have any bearing on the
subject matter of the continuing education program. Disclosure pertains to relationships with any
pharmaceutical companies, biomedical device manufacturers, or other corporations whose products
or services are related to the subject matter of the presentation topic.
The intent of this disclosure is not to prevent a speaker with a potential conflict of interest from mak-
ing a presentation, but to let the audience know about the relationship before the presentation. It is
intended that financial interests or affiliations be openly identified so that, with the full disclosure of
the facts, the attendees may form their own judgments about the presentation.
There were no ICHP faculty conflicts of interest to disclose. Any CIHE or NACCME faculty
conflicts will be disclosed in their respective materials.

Val R. Adams, PharmD, BCOP Adam Bursua, PharmD, BCPS Jennifer C. Ellison, PharmD,
Associate Professor; Medication Safety and Quality BCPS
Clinical Specialist Coordinator Pharmacy Operations Manager
University of Kentucky; University of Illinois Health OSF St. Francis Medical Center
Markey Cancer Center Chicago, IL Peoria, IL
Lexington, KY

Whitnee Caldwell, PharmD Christopher A. Fausel,


Jennifer H. Austin-Szwak, Clinical Pharmacist Specialist, PharmD, BCPS, BCOP
PharmD Internal Medicine Adjunct Associate Professor of
Clinical Pharmacist Specialist, Northwestern Memorial Hospital Medicine; Clinical Manager
Internal Medicine Chicago, IL Oncology Pharmacy
University of Chicago Medicine Indiana University School of
Chicago, IL Medicine; Indiana University
Noelle Chapman, PharmD, Simon Cancer Center
BCPS Indianapolis, IN
Michael Beshir, PharmD Pharmacy Manager Residency
Acute Care Pharmacist Coordinator
Rush University Medical Center Northwestern Memorial Hospital Randolph V. Fugit, PharmD,
Chicago, IL Chicago, IL BCPS
Internal Medicine Clinical Specialist;
Associate Professor of Clinical
Erick Borkowski, PharmD Susan Cornell, PharmD, CDE, Pharmacy
Pharmacy Manager FAPhA, FAADE Denver VA Medical Center;
Northwestern Lake Forest Associate Professor of Pharmacy Skaggs School of Pharmacy and
Hospital Practice and Associate Director of Pharmaceutical Sciences,
Lake Forest, IL Experiential University of Colorado
Education; MTM/Diabetes Care Denver, CO
Provider
Kristin Bradley, PharmD Midwestern University Chicago
PGY-2 Resident, Ambulatory Care College of Pharmacy; Katie Gauen, PharmD
Midwestern University Chicago Bolingbrook Christian Health PGY-2 Resident, Pharmacy
College of Pharmacy Center & Assess Administration
Downers Grove, IL Community Health Network Northwestern Memorial Hospital
Downers Grove, IL Chicago, IL

30 2016 ICHP ANNUAL MEETING


FACULTY & DISCLOSURES

Michelle Geurink, RPh Luke Hvass, PharmD Karen M. Kelly, PharmD


Pharmacy Informatics Specialist PGY-2 Resident, Internal Medicine Pharmacy Manager, Inpatient
OSF HealthCare University of Chicago Medicine Pharmacy
Peoria, IL Chicago, IL NorthShore University
HealthSystem
– Evanston Hospital
Matthew Grissinger, RPh, Diana Isaacs, PharmD, BCPS, Evanston, IL
FISMP, FASCP BC-ADM, CDE
Director, Error Reporting Clinical Pharmacy Specialist
Programs; Manager, Medication Cleveland Clinic Diabetes Center Desi Kotis, PharmD, FASHP
Safety Analysis Cleveland, OH Director of Pharmacy
Institute for Safe Medication Northwestern Memorial Hospital
Practices; Chicago, IL
PA Patient Safety Authority Nadine Isho, PharmD
Horsham, PA Clinical Pharmacist, Specialty
Pharmacy Brian Le, PharmD
Northwestern Memorial Hospital Pharmacy Informatics Resident
Rebekah L. Hanson, PharmD, Chicago, IL Hospital Sisters Health System
BCPS, BCACP Springfield, IL
Clinical Assistant Professor
University of Illinois at Chicago Vern L. Johnson, BS Pharm
College of Pharmacy Director of Pharmacy Christopher Leong, PharmD
Chicago, IL OSF St. Francis Medical Center Clinical Pharmacist Specialist,
Peoria, IL Critical Care
Northwestern Memorial Hospital
Heather M. Harper, PharmD, Chicago, IL
BCPS Abby A. Kahaleh, BS Pharm,
Regional Informatics Pharmacist MS, PhD, MPH
OSF St. Francis Medical Center Associate Professor of Clinical & James S. Lewis II, PharmD,
Peoria, IL Administrative Science FIDSA
Roosevelt University College of Infectious Diseases Clinical
Pharmacy Pharmacy Coordinator
Jack Harris, MEd, LPC Schaumburg, IL Department of Pharmacy and
President Infectious Diseases Oregon
Jack Harris & Associates Health and Science University
Tucson, AZ Alexander Kantorovich, Portland, OR
PharmD, BCPS
Clinical Assistant Professor;
Joshua Hartman, PharmD, MS Clinical Pharmacy Specialist Henri R. Manasse, Jr., PhD, ScD,
Health Informatics Chicago State University FFIP
Clinical Informatics Specialist College of Pharmacy; Advocate Dean and Professor Emeritus
Sinai Health System Christ Medical Center University of Illinois at Chicago
Chicago, IL Chicago, IL College of Pharmacy
Chicago, IL

Deanna Horner, PharmD, BCPS Sharon Karina, PharmD


Clinical Pharmacy Manager Candidate Jennifer Mazan, PharmD
Tenet Healthcare Pharmacy Student Associate Professor
Berwyn, IL Midwestern University Chicago Midwestern University Chicago
College of Pharmacy College of Pharmacy
Downers Grove, IL Downers Grove, IL
David Huhtelin, PharmD
Emergency Medicine Clinical
Pharmacist
SwedishAmerican Hospital
Rockford, IL

LEADERSHIP: IT’S NOT JUST FOR LEADERS! 31


FACULTY & DISCLOSURES

Milena McLaughlin, PharmD, Lalita Prasad-Reddy, PharmD, Sheila Wang, PharmD, BCPS
MSc, BCPS, AAHIVP MS, BCPS, BCACP, CDE AQ-ID
HIV/ID Clinical Pharmacist; Assistant Professor of Pharmacy Associate Professor of Pharmacy
Assistant Professor of Pharmacy Practice Practice
Practice Chicago State University Midwestern University Chicago
Northwestern Memorial Hospital; College of Pharmacy College of Pharmacy
Midwestern University Chicago Chicago, IL Downers Grove, IL
College of Pharmacy
Downers Grove, IL
Julio Rebolledo, PharmD, Eric Wenzler, PharmD
BCPS, AE-C Infectious Disease Research Fellow
Anne Misher, PharmD Assistant Professor of Pharmacy University of Illinois at Chicago
Clinical Assistant Professor Practice College of Pharmacy
University of Georgia Midwestern University Chicago Chicago, IL
Athens, GA College of Pharmacy
Downers Grove, IL
Thomas Wheeler, PharmD,
Mark A. Munger, PharmD, BCPS, CPHIMS
FCCP, FACC Molly Rockstad, PharmD, Corporate Director of Pharmacy
Senior Associate Dean for College BCPS, BCACP Rush University Medical Center
Affairs; Professor of Clinical Pharmacist Chicago, IL
Pharmacotherapy; John H. Stroger Hospital of
Adjunct Professor, Internal Medicine Cook County
University of Utah Chicago, IL Elise M. Wozniak, PharmD
Salt Lake City, UT Pharmacy Practice Coordinator
Northwestern Memorial Hospital
Jasmine Shah, PharmD Chicago, IL
Lisa Palmisano, PharmD, Drug Information Clinical
BCACP Pharmacist
Assistant Professor of Pharmacy Drug Information Group,
Practice University of Illinois at Chicago
Midwestern University Chicago College of Pharmacy
College of Pharmacy Chicago, IL
Downers Grove, IL

Sima Shah, PharmD, MPH


Frank Paloucek, PharmD, 340B Compliance Coordinator;
DABAT, FASHP Clinical Assistant Professor
Director, Residency Programs; University of Illinois Hospital
Clinical Associate Professor in and Health System
Pharmacy Practice, Department of Chicago, IL
Pharmacy Practice
University of Illinois at Chicago
College of Pharmacy Margarita Villarreal-Flores,
Chicago, IL CPhT
Pharmacy Technician Specialist
University of Illinois Health
Jennifer Phillips, PharmD, BCPS Chicago, IL
Drug Information Specialist;
Associate Professor, Pharmacy
Practice Carrie Vogler, PharmD, BCPS
Advocate Lutheran General Clinical Associate Professor
Hospital; Southern Illinois University
Midwestern University Chicago Edwardsville School of
College of Pharmacy Pharmacy
Downers Grove, IL Edwardsville, IL

32 2016 ICHP ANNUAL MEETING


RESIDENCY SHOWCASE

26 Advocate Christ Medical 32 Jewel-Osco Pharmacy 23 St. Elizabeth's Hospital / HSHS


Center and Childrens Hospital Itasca, IL Belleville, IL
Oaklawn, IL 6 Memorial Medical Center 22 Sullivan University College of
11 Aleda E. Lutz VA Medical Center Springfield, IL Pharmacy Residency Program
Saginaw, MI 25 Mercy Health Saint Mary's Louisville, KY
15 Aurora Health Care Grand Rapids, MI 19 Takeda Pharmaceuticals &
Milwaukee, WI 4 Mercy Hospital and Medical Center Purdue University Regulatory
27 Beaumont Hospital Chicago, IL Affairs Fellowship
Royal Oak, MI Deerfield, IL
21 Mount Sinai Hospital/
30 Borgess Medical Center Sinai Health System 1 University of Chicago Medicine
Kalamazoo, MI Chicago, IL Chicago, IL
20 Bronson Healthcare Group 8 Northshore University HealthSystem 2 University of Illinois at Chicago
Kalamazoo, MI Evanston, IL College of Pharmacy
Chicago, IL
34 Captain James A. Lovell FHCC 3 Northwestern Memorial Hospital
North Chicago, IL Chicago, IL 24 University of Minnesota College of
Pharmacy Ambulatory Care
10 Community Healthcare System 28 Ohio Health Riverside
Residency Program
– Community Hospital Methodist Hospital
Multiple sites in MN
Munster, IN Multiple sites in OH
29 UW Madison School of Pharmacy
13 Franciscan St. Elizabeth Health 16 OSF Saint Francis Medical Center/
Community Residency Program
Lafayette, IN Children's Hospital of Illinois
Madison, WI
9 Franciscan St. Margaret Health Peoria, IL
12 VA Center for Medication Safety
Hammond, IN 7 Palos Community Hospital
(VAMedSAFE)
35 Froedtert and the Medical College Palos Heights, IL
Hines, IL
of Wisconsin 14 Presence Health
17 Wheaton Franciscan PGY-1
Milwaukee, WI Joliet, IL
Pharmacy Residency Programs
33 HSHS St. John's Hospital 18 Rush University Medical Center (All Saints, St. Francis, St. Joseph)
Springfield, IL Chicago, IL Milwaukee, WI
31 Jesse Brown VA Medical Center 5 Rutgers Pharmaceutical Industry
Chicago, IL Fellowship Program
Piscataway, NJ
LEADERSHIP: IT’S NOT JUST FOR LEADERS! 33
EXHIBITORS

111 Advanced Patient Care 106 DrFirst 405 Roosevelt University


303 Advanced Pharma, Inc. 116 Eisai Inc. Oncology College of Pharmacy
Silver Sponsor Gold Sponsor 401 Rosalind Franklin University
309 Aethon 108 Equashield LLC College of Pharmacy
204 Allergan 306 Grifols 310 Sagent Pharmaceuticals, Inc.
304 American Regent, Inc. 413 Illinois Medicaid 206/208 Sanofi
402 Amgen 404 Intelliguard RFID Solutions 412 Seqirus
414 Astellas Pharma, US 114 Janssen 210 Shire
308 AuroMedics 406 Kit Check 407 SIUE School of Pharmacy
113 AstraZeneca 311 Lilly USA 112 Stericycle, Inc.
410 Baxter Healthcare Corporation 301 Medicure Pharma 300 Sunovion Pharmaceuticals
408 BD Medical Silver Sponsor 213 Telligen
212 Boehringer- Ingelheim 107/109 Merck 211 Teva Oncology
302 Bristol-Myers Squibb 312 Merck & Co., Inc. 400 Teva Pharma
Silver Sponsor 403 Midwestern University Chicago 100 The Medicines Company
305 CAPS/B. Braun Medical Inc. College of Pharmacy Silver Sponsor
110 Carstens 104 Mylan, Inc. 409 UIC College of Pharmacy
411 Chicago State University 200/202 Novo Nordisk, Inc. 103 UNITED Pharmacy Staffing
College of Pharmacy Platinum Sponsor Silver Sponsor
105 ConsortiEX 102 Omnicell, Inc.
307 Cooper-Atkins Corporation Silver Sponsor
205 Critical Environments 207/209 Otsuka America Pharmaceutical
Professionals, Inc. 101 PharMEDium Services, LLC
201/203 CSL Behring 313 Precision Dose, Inc.

34 2016 ICHP ANNUAL MEETING


NOTES ________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________
LEADERSHIP: IT’S NOT JUST FOR LEADERS! 35
________________________________________________________________________________________________
________________________________________________________________________________________________
________________________________________________________________________________________________
________________________________________________________________________________________________
________________________________________________________________________________________________
________________________________________________________________________________________________
________________________________________________________________________________________________
________________________________________________________________________________________________
________________________________________________________________________________________________
________________________________________________________________________________________________
________________________________________________________________________________________________
________________________________________________________________________________________________
________________________________________________________________________________________________
________________________________________________________________________________________________
________________________________________________________________________________________________
________________________________________________________________________________________________
________________________________________________________________________________________________
________________________________________________________________________________________________
________________________________________________________________________________________________
________________________________________________________________________________________________
________________________________________________________________________________________________
________________________________________________________________________________________________
________________________________________________________________________________________________
________________________________________________________________________________________________
________________________________________________________________________________________________
________________________________________________________________________________________________
________________________________________________________________________________________________
________________________________________________________________________________________________
________________________________________________________________________________________________
________________________________________________________________________________________________
________________________________________________________________________________________________
________________________________________________________________________________________________
________________________________________________________________________________________________
________________________________________________________________________________________________
________________________________________________________________________________________________
________________________________________________________________________________________________
________________________________________________________________________________________________
________________________________________________________________________________________________
________________________________________________________________________________________________
________________________________________________________________________________________________
________________________________________________________________________________________________
________________________________________________________________________________________________
________________________________________________________________________________________________
________________________________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________
36 2016 ICHP ANNUAL MEETING
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________
LEADERSHIP: IT’S NOT JUST FOR LEADERS! 37
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________
38 2016 ICHP ANNUAL MEETING
Upcoming Events
2016 - 2017

ICHP Leadership Retreat Pharmacy Legislative Day ICHP/MSHP Spring Meeting


(invitation only) March 15, 2017 March 30-April 1, 2017
November 4-5, 2016 Springfield, IL Collinsville, IL
Galena, IL

Visit us at Booth #116

LEADERSHIP: IT’S NOT JUST FOR LEADERS! 39


Visit us at
BOOTH
#301
at the ICHP Annual Meeting

Visit www.aggrastatHDB.com

For more information, call 1-800-509-0544 (#5)

You might also like